STRATA Skin Sciences, Inc. announced an exclusive agreement with MINO Labs, a private company that represents international pharmaceutical companies to commercialize innovative products in Mexico, for the distribution of TheraClear®X, VTRAC® and XTRAC® in Mexico for three years.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3854 USD | -2.08% | +0.29% | -29.94% |
15/05 | Transcript : STRATA Skin Sciences, Inc., Q1 2024 Earnings Call, May 15, 2024 | |
15/05 | Earnings Flash (SSKN) STRATA SKIN SCIENCES Reports Q1 Revenue $6.8M, vs. Street Est of $6.9M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.94% | 1.38Cr | |
+12.34% | 23TCr | |
+15.53% | 20TCr | |
+18.42% | 14TCr | |
+30.70% | 11TCr | |
+0.53% | 6.41TCr | |
+17.69% | 5.37TCr | |
+6.33% | 5.17TCr | |
+11.07% | 4.52TCr | |
+6.82% | 3.74TCr |
- Stock Market
- Equities
- SSKN Stock
- News STRATA Skin Sciences, Inc.
- STRATA Skin Sciences, Inc. Expands into $300 Million Market with Exclusive Distribution Agreement in Mexico